Wilson Sonsini Goodrich & Rosati advised OneSkin on intellectual property matters related to the transaction. OneSkin, a biotech skin health brand, announced the completion of an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Amber on the transaction. Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Future Health Works on the deal. Healthcare Outcomes Performance Company (HOPCo), a U.S. leader in musculoskeletal (MSK) physician practice management, outcomes management, and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised NanoCellect on the deal. Microfluidic cell sorting company NanoCellect Biomedical announced the closing of $35 million in Series C and...
You must be a Standard 1 Year member to access this content.
